FDA warned Western Herb Products over adulterated, misbranded Wormwood/Aloes capsules and serious dietary supplement manufacturing violations.
What happened
FDA inspected Western Herb Products’ dietary supplement facility in Index, Washington, on May 3, 4, and 12, 2021. FDA said the firm did not establish required current good manufacturing practice (CGMP) specifications, manufacturing and batch records, quality control procedures, or complaint procedures, and that its Wormwood/Aloes product was misbranded. FDA reviewed the firm’s May 31, 2021 response and found the proposed corrections inadequate.
What FDA found
The firm did not establish required written specifications for ingredients, in-process steps, and finished Wormwood/Aloes capsules.
21 CFR 111.70(a), (b), (c), (e)The master manufacturing record for Wormwood/Aloes lacked required information such as ingredient strength, component list, weights, yield limits, and instructions.
21 CFR 111.205(a), 21 CFR 111.210Batch production records lacked required details such as equipment identity, cleaning dates, component weights, yields, test results, and quality review.
21 CFR 111.255(a), 21 CFR 111.260The firm had no written quality control procedures for material review, disposition decisions, and approving or rejecting processing.
21 CFR 111.103The firm had no adequate written procedure for reviewing and investigating product complaints.
21 CFR 111.553, 21 CFR 111.560The Wormwood/Aloes label did not correctly identify the plant part used, and other label information did not comply.
section 403(s)(2)(C) of the Act [21 U.S.C. § 343(s)(2)(C)]; 21 CFR 101.4(h)(1)
What FDA wants
FDA tells the company to respond in writing within 15 working days of receipt, describing specific corrective steps, explaining how recurrence will be prevented, and providing related documents. If corrections cannot be completed in that time, the company must state why and give a completion date.
Who should pay attention
- dietary supplement brands using contract manufacturers
- retailers and distributors of herbal supplement capsules
- quality teams handling botanical identity and supplier specifications
This is a summary. Read the original letter on fda.gov.